These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11583944)

  • 1. Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease.
    Stahl PJ; Felsen D
    Am J Pathol; 2001 Oct; 159(4):1187-92. PubMed ID: 11583944
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation.
    Zeisberg M; Bonner G; Maeshima Y; Colorado P; Müller GA; Strutz F; Kalluri R
    Am J Pathol; 2001 Oct; 159(4):1313-21. PubMed ID: 11583959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation.
    Carvajal G; Rodríguez-Vita J; Rodrigues-Díez R; Sánchez-López E; Rupérez M; Cartier C; Esteban V; Ortiz A; Egido J; Mezzano SA; Ruiz-Ortega M
    Kidney Int; 2008 Sep; 74(5):585-95. PubMed ID: 18509316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The "Snail" genes and renal diseases: what we learn from organogenesis].
    Boutet A; Nieto MA
    Med Sci (Paris); 2008 Mar; 24(3):238-40. PubMed ID: 18334166
    [No Abstract]   [Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition in renal tubular cells in the pathogenesis of progressive tubulo-interstitial fibrosis.
    Mucsi I; Rosivall L
    Acta Physiol Hung; 2007 Mar; 94(1-2):117-31. PubMed ID: 17444280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of epithelial to mesenchymal transdifferentiation in end-stage renal disease.
    Sam R
    Int J Artif Organs; 2004 Sep; 27(9):744-50. PubMed ID: 15521213
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of transforming growth factor-beta in transdifferentiation and fibrosis of lens epithelial cells.
    Lee EH; Joo CK
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2025-32. PubMed ID: 10440257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epithelial-mesenchymal transition and hepatocellular carcinoma].
    Battaglia S; Benzoubir N; Ghigna MR; Guettier C; Bréchot C; Bourgeade MF
    Ann Pathol; 2009 Nov; 29 Spec No 1():S65-6. PubMed ID: 19887256
    [No Abstract]   [Full Text] [Related]  

  • 9. AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling.
    Kong B; Michalski CW; Hong X; Valkovskaya N; Rieder S; Abiatari I; Streit S; Erkan M; Esposito I; Friess H; Kleeff J
    Oncogene; 2010 Sep; 29(37):5146-58. PubMed ID: 20581862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of epithelial-to-mesenchymal transition in renal fibrosis.
    Zeisberg M; Kalluri R
    J Mol Med (Berl); 2004 Mar; 82(3):175-81. PubMed ID: 14752606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition.
    Slattery C; Campbell E; McMorrow T; Ryan MP
    Am J Pathol; 2005 Aug; 167(2):395-407. PubMed ID: 16049326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tubular epithelial-mesenchymal transition in progressive kidney disease.
    Burns WC; Kantharidis P; Thomas MC
    Cells Tissues Organs; 2007; 185(1-3):222-31. PubMed ID: 17587828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of epithelial-mesenchymal transition in kidney. The contribution of a coupled histochemical and immunohistochemical staining with Periodic Acid-thionin Schiff.
    Santos MC; Musso C; Alves VA; Zatz R; Fujihara CK; Malheiros DM
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):191-5. PubMed ID: 18227721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta in renal injury and disease.
    Böttinger EP
    Semin Nephrol; 2007 May; 27(3):309-20. PubMed ID: 17533008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epithelial-mesenchymal transition: fact or fiction in cancer?
    Giannelli G
    Hepatology; 2009 Nov; 50(5):1344-6. PubMed ID: 19877297
    [No Abstract]   [Full Text] [Related]  

  • 16. Renoprotective properties of pirfenidone in subtotally nephrectomized rats.
    Takakuta K; Fujimori A; Chikanishi T; Tanokura A; Iwatsuki Y; Yamamoto M; Nakajima H; Okada M; Itoh H
    Eur J Pharmacol; 2010 Mar; 629(1-3):118-24. PubMed ID: 20006961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis.
    Rastaldi MP
    J Nephrol; 2006; 19(4):407-12. PubMed ID: 17048197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
    Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
    Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis.
    Roberts AB; Tian F; Byfield SD; Stuelten C; Ooshima A; Saika S; Flanders KC
    Cytokine Growth Factor Rev; 2006; 17(1-2):19-27. PubMed ID: 16290023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdifferentiation: a new angle on renal fibrosis.
    Strutz F; Müller GA; Neilson EG
    Exp Nephrol; 1996; 4(5):267-70. PubMed ID: 8931981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.